Cas no 61303-13-7 (Isoacteoside)

Isoacteoside is a bioactive phenylethanoid glycoside found in various medicinal plants, including Orobanche and Plantago species. It exhibits notable antioxidant, anti-inflammatory, and neuroprotective properties, making it a compound of interest in pharmacological research. Structurally, it features a caffeoyl group linked to a glucose moiety, contributing to its free radical scavenging activity. Studies suggest potential applications in mitigating oxidative stress-related disorders and neurodegenerative conditions. Its stability and solubility profile facilitate formulation in both aqueous and organic matrices. Analytical methods such as HPLC and LC-MS are commonly employed for its identification and quantification, ensuring high purity for research and development purposes.

Isoacteoside structure

Product Name:Isoacteoside

CAS No:61303-13-7

MF:C₂₉H₃₆O₁₅

MW:624.58715057373

MDL:MFCD06798947

CID:57667

PubChem ID:6476333

Update Time:2025-10-18

Isoacteoside Chemical and Physical Properties

Names and Identifiers

- Isoacteoside
- [(2R,3R,4S,5R,6R)-5-(3,4-Dihydroxyphenyl)-6-ethoxy-3,5-dihydroxy-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]methyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
- b-D-Glucopyranoside,2-(3,4-dihydroxyphenyl)ethyl 3-O-(6-deoxy-a-L-mannopyranosyl)-,6-[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoate]
- Isoverbascoside
- ISOVERBASCOSIDE(P)
- isoacetoside
- Isoacteosid
- verbascoside
- (E)-2-(3,4-dihydroxyphenyl)ethyl 3-O-(6-deoxy-α-L-mannopyranosyl)-, 6-(3-(3,4-dihydroxyphenyl)-β-D-glucopyranoside
- [ "" ]
- 588LJK42AP
- iso-acteoside
- Acteoside isomer
- Verbascoside,(S)
- [(2R,3R,4S,5R,6R)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-3,5-dihydroxy-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]methyl (E)-3-(3,4-dihydroxyphenyl
- .BETA.-D-GLUCOPYRANOSIDE, 2-(3,4-DIHYDROXYPHENYL)ETHYL 3-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-, 6-((2E)-3-(3,4-DIHYDROXYPHENYL)-2-PROPENOATE)
- UNII-588LJK42AP
- (E)-((2R,3R,4S,5R,6R)-6-(3,4-dihydroxyphenethoxy)-3,5-dihydroxy-4-((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yl)methyl 3-(3,4-dihydroxyphenyl)acrylate
- beta-D-Glucopyranoside, 2-(3,4-dihydroxyphenyl)ethyl 3-O-(6-deoxy-alpha-L-mannopyranosyl)-, 6-(3-(3,4-dihydroxyphenyl)-2-propenoate), (E)-
- 2-(3',4'-dihydroxyphenyl)ethyl 6-O-caffeoyl-3-O-(alpha-l-rhamnopyranosyl)-beta-d-glucopyranoside
- NSC729649
- s9128
- HY-N0022
- NSC-729649
- MS-30813
- [(2R,3R,4S,5R,6R)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-3,5-dihydroxy-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]methyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
- NS00094507
- AKOS037514697
- beta-D-GLUCOPYRANOSIDE, 2-(3,4-DIHYDROXYPHENYL)ETHYL 3-O-(6-DEOXY-alpha-L-MANNOPYRANOSYL)-, 6-((2E)-3-(3,4-DIHYDROXYPHENYL)-2-PROPENOATE)
- CHEBI:192072
- Q27261572
- [(2R,3R,4S,5R,6R)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-3,5-dihydroxy-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]methyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
- .beta.-D-Glucopyranoside, 2-(3,4-dihydroxyphenyl)ethyl 3-O-(6-deoxy-.alpha.-L-mannopyranosyl)-6-O-[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]-
- CCG-270268
- CHEMBL504873
- BDBM50386896
- MFCD06798947
- DTXSID501317837
- ((2R,3R,4S,5R,6R)-6-(3,4-Dihydroxyphenethoxy)-3,5-dihydroxy-4-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)methyl (E)-3-(3,4-dihydroxyphenyl)acrylate
- NSC 729649
- Q-100709
- 61303-13-7
- FNMHEHXNBNCPCI-QEOJJFGVSA-N
- DA-64514
- 1ST167466
- MDL： MFCD06798947
- Inchi： 1S/C29H36O15/c1-13-22(35)24(37)25(38)29(42-13)44-27-23(36)20(12-41-21(34)7-4-14-2-5-16(30)18(32)10-14)43-28(26(27)39)40-9-8-15-3-6-17(31)19(33)11-15/h2-7,10-11,13,20,22-33,35-39H,8-9,12H2,1H3/b7-4+/t13-,20+,22-,23+,24+,25+,26+,27-,28+,29-/m0/s1
- InChI Key： FNMHEHXNBNCPCI-QEOJJFGVSA-N
- SMILES： O([C@H]1[C@@H]([C@@H]([C@H]([C@H](C)O1)O)O)O)[C@@H]1[C@H]([C@H](OCCC2C=CC(=C(C=2)O)O)O[C@H](COC(/C=C/C2C=CC(=C(C=2)O)O)=O)[C@H]1O)O

Computed Properties

Exact Mass: 624.20500
Monoisotopic Mass: 624.20542044 g/mol
Isotope Atom Count: 0
Hydrogen Bond Donor Count: 9
Hydrogen Bond Acceptor Count: 15
Heavy Atom Count: 44
Rotatable Bond Count: 11
Complexity: 936
Covalently-Bonded Unit Count: 1
Defined Atom Stereocenter Count: 10
Undefined Atom Stereocenter Count : 0
Defined Bond Stereocenter Count: 1
Undefined Bond Stereocenter Count: 0
Molecular Weight: 624.6
XLogP3: -0.5
Topological Polar Surface Area: 245

Experimental Properties

Color/Form: Powder
Density: 1.6
Melting Point: No data available
Boiling Point: 942.9℃/760mmHg
Flash Point: 306.1±27.8 °C
Refractive Index: 1.689
Solubility: 生物體外In Vitro:DMSO溶解度≥ 48 mg/mL(76.85 mM)*"≥" means soluble可溶, but saturation unknown溶解度未知.
PSA: 245.29000
LogP: -1.01590

Isoacteoside Security Information

Signal Word：warning
Hazard Statement： H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
Warning Statement： P264Thoroughly clean after treatment
P280Wear protective gloves/Wear protective clothing/Wear protective goggles/Wear a protective mask
P305If it enters the eyes
P351Rinse carefully with water for a few minutes
P338Remove the contact lens(If any)And easy to operate,Continue flushing
P337If eye irritation persists
P313Obtain medical advice/care
Safety Instruction： H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
Storage Condition：Powder -20°C 3 years ? 4°C 2 years In solvent -80°C 6 months ? -20°C 1 month

Isoacteoside Pricemore >>

Related Categories	No.	Product Name	Cas No.	Purity	Specification	Price	update time
SHANG HAI XIAN DING Biotechnology Co., Ltd.	UF972-20mg	Isoacteoside	61303-13-7	HPLC≥95+%	20mg	1564CNY	2021-05-08
XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd.	PHL89232-10MG	Isoverbascoside	61303-13-7		10mg	￥5786.06	2023-10-14
XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd.	SMB01011-1MG	Isoacteoside	61303-13-7		1mg	￥2463.98	2023-09-13
TRC	I782000-1mg	Isoacteoside	61303-13-7		1mg	40.00	2021-08-04
TRC	I782000-2.5mg	Isoacteoside	61303-13-7		2.5mg	80.00	2021-08-04
TRC	I782000-5mg	Isoacteoside	61303-13-7		5mg	145.00	2021-08-04
TRC	I782000-10mg	Isoacteoside	61303-13-7		10mg	240.00	2021-08-04
Chengdu Biopurify Phytochemicals Ltd	BP0770-100mg	Isoacteoside	61303-13-7	98%	100mg	$290	2023-09-20
Chengdu Biopurify Phytochemicals Ltd	BP0770-20mg	Isoacteoside	61303-13-7	98%	20mg	$96	2023-09-20
SHANG HAI YUAN YE Biotechnology Co., Ltd.	B21535-20mg	Isoacteoside	61303-13-7	,HPLC≥98%	20mg	￥1000.00	2021-09-02

Isoacteoside Production Method

Isoacteoside Suppliers

Hubei Cuiyuan Biotechnology Co.,Ltd

Gold Member

Audited Supplier

(CAS:61303-13-7)Isoacteoside

Order Number:CRN0632

Stock Status:in stock

Quantity:5mg/20mg/50mg

Purity:≥98%

Pricing Information Last Updated:Friday, 14 March 2025 10:55

Price ($):

Email:[email protected]

Product Official Link

Isoacteoside Related Literature

1. Rapid extraction, discrimination and quantification of thermally unstable isomeric acteoside and isoacteoside in natural products by online extraction-quadrupole time-of-flight tandem mass spectrometry

Chaoying Tong,Jinju Xu,Qiachi Fu,Ruiqing Long,Sheng Peng,Shuyun Shi Anal. Methods 2019 11 2148
2. Screening of neuraminidase inhibitors from the leaves of Syringa velutina Kom. via compound fractionation and in vitro activity evaluation

Yuchi Zhang,Jingying Xu,Chunming Liu,Sainan Li Anal. Methods 2017 9 500
3. A deep clustering-based mass spectral data visualization strategy for anti-renal fibrotic lead compound identification from natural products

Jieying Lai,Lichuang Huang,Yini Bao,Lu Wang,Qiang Lyu,Haodan Kuang,Kuilong Wang,Xianan Sang,Qiao Yang,Qiyuan Shan,Gang Cao Analyst 2022 147 4739
4. Metabolome profiling and molecular docking analysis revealed the metabolic differences and potential pharmacological mechanisms of the inflorescence and succulent stem of Cistanche deserticola

Xiao Sun,Yan Zheng,Lixia Tian,Yujing Miao,Tiexin Zeng,Yuan Jiang,Jin Pei,Bashir Ahmad,Linfang Huang RSC Adv. 2021 11 27226
5. Integrated analysis of phytochemical composition, pharmacokinetics, and network pharmacology to probe distinctions between the stems of Cistanche deserticola and C. tubulosa based on antidepressant activity

Li Fan,Ying Peng,Xiaonan Chen,Ping Ma,Xiaobo Li Food Funct. 2022 13 8542

Related Categories

61303-13-7 (Isoacteoside) Related Products

Recommended suppliers